IMMUNITYBIO, INC. Available-for-sale Securities
IMMUNITYBIO, INC. (IBRX) had Available-for-sale Securities of $0 as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2019-05-08
- 2019-03-31: Available-for-sale Securities $0.00.
- 2018-12-31: Available-for-sale Securities $0.00.
- 2018-06-30: Available-for-sale Securities $101.76M.
- 2018-03-31: Available-for-sale Securities $125.68M.
| Period end | Available-for-sale Securities |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-12-31 | $0.00 10-Q · filed 2019-05-08 |
| 2018-06-30 | $101.76M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $125.68M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $137.38M 10-K · filed 2019-03-13 |
| 2017-09-30 | $165.54M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $197.51M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $248.86M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $280.41M 10-K · filed 2018-03-12 |
| 2016-09-30 | $288.98M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $283.47M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $299.72M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $191.48M 10-K · filed 2017-03-15 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |